Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $87,684.02 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 11,447 shares of the stock in a transaction on Tuesday, April 16th. The shares were sold at an average price of $7.66, for a total transaction of $87,684.02. Following the completion of the sale, the director now directly owns 7,229,861 shares in the […]

Related Keywords

Canada ,China ,Blake Borgeson ,First Horizon Advisors Inc ,Nasdaq ,Quarter For Recursion Pharmaceuticals ,Recursion Pharmaceuticals Stock Performance ,Recursion Pharmaceuticals ,Needham Company ,National Bank ,Securities Exchange Commission ,China Universal Asset Management Co ,News Ratings For Recursion Pharmaceuticals Daily ,Keycorp ,Comerica Bank ,Recursion Pharmaceuticals Inc ,Get Free Report ,Director Blake Borgeson ,Exchange Commission ,Universal Asset Management ,First Horizon Advisors ,Recursion Pharmaceuticals Daily ,Nasdaq Rxrx ,Rxrx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,